METHOD FOR PREDICTING THE OUTCOME OF A TREATMENT WITH AFLIBERCEPT OF A PATIENT SUSPECTED TO SUFFER FROM A CANCER BY MEASURING THE LEVEL OF A PLASMA BIOMARKER
Jennifer DREYMANN,Caroline PACCARD,Marielle CHIRON-BLONDEL
申请号：
US15414722
公开号：
US20180113134A1
申请日:
2017.01.25
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention concerns the use of VCAM-1, ICAM-1 and/or PIGF as biomarkers for predicting the outcome of the treatment with aflibercept, or ziv-aflibercept of a patient suspected to suffer from a cancer.
